Keros Therapeutics, Inc. (KROS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Keros Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 8.71x | -3.16x | -7.65x | -11.58x | -23.24x | -24.11x |
| P/B Ratio | 2.50x | 1.04x | 3.52x | 4.37x | 5.61x | 4.18x |
| P/S Ratio | 3.11x | 166.94x | 7753.76x | 0.00x | 67.92x | 0.00x |
| Profitability | ||||||
| Gross Margin | 99.4% | 100.0% | 100.0% | 0.0% | 100.0% | 0.0% |
| Operating Margin | 28.9% | -5939.0% | -112543.7% | 0.0% | -280.5% | 0.0% |
| Net Margin | 35.7% | -5277.5% | -101319.2% | 0.0% | -292.3% | 0.0% |
| EBITDA Margin | 29.6% | -5234.5% | -100779.5% | 0.0% | -280.4% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 15.45x | 21.45x | 14.25x | 17.27x | 21.23x | 37.27x |
| Quick Ratio | 15.45x | 21.45x | 14.25x | 17.27x | 21.23x | 37.27x |
| Leverage | ||||||
| Debt/Equity | 0.06x | 0.03x | 0.04x | 0.05x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..